TP-20 (ATXA Therapeutics)

N/A

Report date: 2025/01/20 10:34:38
NME

Base Information

Drug NameTP-20 (ATXA Therapeutics)
Drug Alias NameTP-20TP20
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 receptor antagonists
TargetsThromboxane A2 receptor
Therapy Area/IndicationsCardiovascular DiseasesPulmonary Arterial HypertensionNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesATXA Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesATXA Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsCardiovascular DiseasesPulmonary Arterial HypertensionNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A